EUVIMEDEUVIMED entdecken
Crossref

REV-ERBα Mitigates Astrocyte Activation and Protects Dopaminergic Neurons from Damage

Xiaoyu Wang, Hui Zhi, Zongqin Zhang, Jingwei Li, Dongkai Guo

Journal of Molecular Neuroscience · 2024

DOI: 10.1007/s12031-024-02264-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Neuroscience, 2024. Verfasst von Xiaoyu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, 215153, China. Hauptthemen laut MEDLINE: Astrocytes, Nuclear Receptor Subfamily 1, Group D, Member 1, Dopaminergic Neurons. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is characterized by astrocyte activation and disruptions in circadian rhythm. Within the astrocyte population, two distinct reactive states exist: A1 and A2. A1 astrocytes are associated with neurotoxicity and inflammation, while A2 astrocytes exhibit neuroprotective functions. Our investigation focused on the role of REV-ERBα, a member of the nuclear receptor superfamily and a key regulator of the circadian clock, in astrocyte activation. We observed that REV-ERBα expression in A1 astrocytes was reduced to one-third of its normal level. Notably, activation of REV-ERBα prompted a transformation of astrocytes from A1 to A2. Mechanistically, REV-ERBα inhibition was linked to the classical NF-κB pathway, while it concurrently suppressed the STAT3 pathway. Furthermore, astrocytes with low REV-ERBα expression were associated with dopaminergic neurons apoptosis. Intriguingly, the opposite effect was observed when using a REV-ERBα agonist, which mitigated astrocyte activation and reduced dopaminergic neuron damage by 50%. In summary, our study elucidates the pivotal role of REV-ERBα in modulating astrocyte function and its potential implications in PD pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesNuclear Receptor Subfamily 1, Group D, Member 1Dopaminergic NeuronsAnimalsMiceCells, CulturedNF-kappa BSTAT3 Transcription FactorApoptosisMice, Inbred C57BLSignal Transduction

Stichwörter der Autor:innen

Astrocyte activationDopaminergic neuronsParkinson’ diseaseREV-ERBα

Substanzen

Nuclear Receptor Subfamily 1, Group D, Member 1Nr1d1 protein, mouseNF-kappa BSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, 215153, China.
  • Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, 215002, China.
  • Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, 215153, China. ljw323@yeah.net.
  • Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, 215153, China. dongkaiguo@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, X., Zhi, H., Zhang, Z., Li, J., & Guo, D. (2024). REV-ERBα Mitigates Astrocyte Activation and Protects Dopaminergic Neurons from Damage. Journal of Molecular Neuroscience. https://doi.org/10.1007/s12031-024-02264-w

Vancouver

Wang X, Zhi H, Zhang Z, Li J, Guo D. REV-ERBα Mitigates Astrocyte Activation and Protects Dopaminergic Neurons from Damage. Journal of Molecular Neuroscience. 2024. doi:10.1007/s12031-024-02264-w

BibTeX
@article{Wang2024,
  author = {Wang, Xiaoyu and Zhi, Hui and Zhang, Zongqin and Li, Jingwei and Guo, Dongkai},
  title = {REV-ERBα Mitigates Astrocyte Activation and Protects Dopaminergic Neurons from Damage},
  journal = {Journal of Molecular Neuroscience},
  year = {2024},
  doi = {10.1007/s12031-024-02264-w}
}
Kostenlos starten →